Longest Survival after Aortic Valve Replacement with Bioprosthesis: A 38 Year Follow-Up

Mohsin, Ibrahim; Fatima, Safa; Ahmed, Mustafa

doi:10.47275/2690-862x-101

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The recent echocardiogram done on May 1, 2023, showed no significant abnormality of the bioprosthetic valve, in terms of neither stenosis nor regurgitation, which attests to the lack of any significant SVD, if any. This case report provides essential data on the durability of bioprosthetic valves for further research regarding degeneration, as well as potential options for improvement [ 6 ].…”

Section: Introductionmentioning

confidence: 99%

The Longest Known Survival of a Patient With Bioprosthetic Aortic Valve Replacement: A 42-Year Follow-Up

Ahmed,

Samant

et al. 2023

Cureus

Self Cite

View full text Add to dashboard Cite

Aortic valve replacement (AVR) is a frequently performed procedure for treating aortic valvulopathy. AVR involves replacing the damaged aortic valve with either a mechanical or a bioprosthetic valve. While many factors are involved when selecting between the two options, age and patient preference are the deciding factors at this point. Mechanical valves demonstrate long-standing durability that overlaps with the accompanied bleeding risk due to lifetime anticoagulant therapy, making them a more favorable choice for younger patients. Bioprosthetic valves are preferred for older patients as they show a reduced risk of thrombogenicity. However, bioprosthetic valves have a higher incidence of structural valve degeneration (SVD) than mechanical valves. Our case report focuses on a 76-year-old patient who had undergone an AVR with a bioprosthetic valve at the age of 33, which has still not demonstrated any valve deterioration. As the longest known case of bioprosthetic durability, this patient provides useful data for designing bioprosthetic valves more resistant to structural degeneration and thereby better suited to younger patients or those at higher risk of bleeding.

show abstract

Section: Introductionmentioning

confidence: 99%